WAVE Life Sciences Ltd
WVE6.960USD
+0.160+2.35%
Fechamento 09/18, 16:00（ET）Cotações atrasadas em 15 min
1.08BValor de mercado
PerdaP/L TTM
Mais detalhes de WAVE Life Sciences Ltd Empresa
Wave Life Sciences Ltd. is a biotechnology company. The Company is focused on unlocking the potential of RNA medicines (oligonucleotides), or those targeting ribonucleic acid (RNA), to transform human health. Its RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing and RNA interference (RNAi), providing Company with capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency and Huntington’s disease, as well as a preclinical program in obesity. These programs include WVE-N531, WVE-006 and WVE-003. It is also building a pipeline of novel A-to-I RNA editing oligonucleotides (AIMers).
Informações da empresa
Código da empresaWVE
Nome da EmpresaWAVE Life Sciences Ltd
Data de listagemNov 11, 2015
CEODr. Paul B. Bolno, M.D.
Número de funcionários287
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 11
Endereço7 Straits View
Cidade
Bolsa de valoresNASDAQ Global Market Consolidated
PaísSingapore
Código postal018936
Telefone6562363388
Sitehttps://www.wavelifesciences.com/
Código da empresaWVE
Data de listagemNov 11, 2015
CEODr. Paul B. Bolno, M.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Chandra Vargeese, Ph.D.
Dr. Chandra Vargeese, Ph.D.
Chief Technology Officer, Head - Platform Discovery Sciences
Chief Technology Officer, Head - Platform Discovery Sciences
302.31K
--
Ms. Aik Na Tan
Ms. Aik Na Tan
Independent Director
Independent Director
40.39K
+150.62%
Ms. Heidi L. Wagner, J.D.
Ms. Heidi L. Wagner, J.D.
Independent Director
Independent Director
28.82K
+78.81%
Mr. Kyle Moran
Mr. Kyle Moran
Chief Financial Officer
Chief Financial Officer
25.00K
--
Mr. Ken Takanashi
Mr. Ken Takanashi
Independent Director
Independent Director
23.94K
+48.58%
Mr. Christian O. Henry
Mr. Christian O. Henry
Independent Chairman of the Board
Independent Chairman of the Board
19.14K
+18.80%
Dr. Paul B. Bolno, M.D.
Dr. Paul B. Bolno, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Christopher John Francis, Ph.D.
Dr. Christopher John Francis, Ph.D.
Senior Vice President - Corporate Development, Head - Emerging Areas
Senior Vice President - Corporate Development, Head - Emerging Areas
--
--
Dr. Gregory L. (Greg) Verdine, Ph.D.
Dr. Gregory L. (Greg) Verdine, Ph.D.
Director
Director
--
--
Dr. Peter Kolchinsky, Ph.D.
Dr. Peter Kolchinsky, Ph.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Chandra Vargeese, Ph.D.
Dr. Chandra Vargeese, Ph.D.
Chief Technology Officer, Head - Platform Discovery Sciences
Chief Technology Officer, Head - Platform Discovery Sciences
302.31K
--
Ms. Aik Na Tan
Ms. Aik Na Tan
Independent Director
Independent Director
40.39K
+150.62%
Ms. Heidi L. Wagner, J.D.
Ms. Heidi L. Wagner, J.D.
Independent Director
Independent Director
28.82K
+78.81%
Mr. Kyle Moran
Mr. Kyle Moran
Chief Financial Officer
Chief Financial Officer
25.00K
--
Mr. Ken Takanashi
Mr. Ken Takanashi
Independent Director
Independent Director
23.94K
+48.58%
Mr. Christian O. Henry
Mr. Christian O. Henry
Independent Chairman of the Board
Independent Chairman of the Board
19.14K
+18.80%
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: qui, 15 de mai
Atualizado em: qui, 15 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
RA Capital Management, LP
11.44%
GSK plc
10.54%
Adage Capital Management, L.P.
9.43%
BlackRock Institutional Trust Company, N.A.
5.50%
Maverick Capital, Ltd.
5.19%
Outro
57.91%
Investidores
Investidores
Proporção
RA Capital Management, LP
11.44%
GSK plc
10.54%
Adage Capital Management, L.P.
9.43%
BlackRock Institutional Trust Company, N.A.
5.50%
Maverick Capital, Ltd.
5.19%
Outro
57.91%
Tipos de investidores
Investidores
Proporção
Investment Advisor
31.43%
Hedge Fund
24.51%
Investment Advisor/Hedge Fund
16.55%
Corporation
15.30%
Venture Capital
11.51%
Research Firm
2.29%
Individual Investor
0.49%
Bank and Trust
0.29%
Pension Fund
0.25%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
364
156.69M
98.46%
-1.61M
2025Q1
368
156.82M
101.38%
+1.16M
2024Q4
342
152.89M
100.27%
+6.14M
2024Q3
306
144.44M
97.59%
+25.71M
2024Q2
274
116.00M
94.13%
+429.46K
2024Q1
255
115.83M
95.69%
+2.66M
2023Q4
240
115.18M
98.42%
+19.70M
2023Q3
224
93.79M
97.86%
+5.83M
2023Q2
224
93.41M
97.80%
+7.66M
2023Q1
249
91.33M
96.13%
+7.12M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
RA Capital Management, LP
18.20M
11.7%
--
--
Mar 31, 2025
GSK plc
16.78M
10.78%
--
--
Jun 06, 2025
Adage Capital Management, L.P.
12.52M
8.05%
+2.89M
+30.08%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
8.21M
5.28%
+200.47K
+2.50%
Mar 31, 2025
Maverick Capital, Ltd.
8.26M
5.31%
+441.00
+0.01%
Mar 31, 2025
Driehaus Capital Management, LLC
6.36M
4.09%
-353.85K
-5.27%
Mar 31, 2025
Shin Nippon Biomedical Laboratories Ltd
5.71M
3.67%
--
--
Jun 06, 2025
M28 Capital Management LP
5.66M
3.64%
--
--
Mar 31, 2025
Emerald Advisers LLC
5.06M
3.26%
-29.02K
-0.57%
Mar 31, 2025
T. Rowe Price Associates, Inc.
4.03M
2.59%
-969.83K
-19.40%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de set
Atualizado em: sáb, 6 de set
Nome
Proporção
iShares Health Innovation Active ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
Vanguard US Momentum Factor ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
SPDR Portfolio MSCI Global Stock Market ETF
0%
iShares ESG Aware MSCI USA Small-Cap ETF
0%
Avantis US Equity ETF
0%
iShares Neuroscience and Healthcare ETF
0%
Ver Mais
iShares Health Innovation Active ETF
Proporção0%
Invesco NASDAQ Future Gen 200 ETF
Proporção0%
Vanguard US Momentum Factor ETF
Proporção0%
Fidelity Nasdaq Composite Index ETF
Proporção0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporção0%
SPDR Portfolio MSCI Global Stock Market ETF
Proporção0%
iShares ESG Aware MSCI USA Small-Cap ETF
Proporção0%
Avantis US Equity ETF
Proporção0%
iShares Neuroscience and Healthcare ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
